IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling

Chengxin Li, Sumin Chi, Nonggao He, Xiaoli Zhang, Oivin Guicherit, Richard Wagner, Stephen Tyring, Jingwu Xie

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Basal cell carcinoma (BCC), the most common form of human cancer, is understood to be associated with activation of the sonic hedgehog pathway, through loss-of-function mutations of tumor suppressor PTCH1 or gain-of-function mutations of smoothened. Interferon (IFN)-based therapy is quite effective in BCC treatment, but the molecular basis is not well understood. Here we report a novel mechanism by which IFNα mediates apoptosis in BCCs. In the presence of IFNα, we observed increased apoptosis in a BCC cell line ASZ001, in which PTC is null, and therefore with constitutive activation of the sonic hedgehog pathway. We demonstrate that SMO agonist Ag-1.4 mediates activation of extracellular signal-regulated kinase (Erk) phosphorylation, which is abrogated by IFNα in sonic hedgehog responsive C3H10T1/2 cells. In transient transfection experiments, we demonstrate that IFNα inhibits Erk phosphorylation and serum response element activation induced by expression of SMO, Gli1, PDGFRα and activated Raf, but not activated mitogen-activated Erk-regulating kinase (Mek), suggesting that IFNα targets mainly on Mek function. We further show that IFNa induces expression of Fas in BCC cells through interfering with Mek function. The role of the Fas-L/Fas signaling axis in IFNα-mediated apoptosis is demonstrated by the fact that addition of Fas-L neutralizing antibodies, just as caspase-8 inhibitor Z-IETD-FMK, effectively prevents IFNα-mediated apoptosis. Thus, our data indicate that IFNα-based BCC therapy induces Fas expression and apoptosis through interfering with Mek function.

Original languageEnglish (US)
Pages (from-to)1608-1617
Number of pages10
JournalOncogene
Volume23
Issue number8
DOIs
StatePublished - Feb 26 2004

Fingerprint

Basal Cell Carcinoma
Extracellular Signal-Regulated MAP Kinases
Interferons
Apoptosis
Mitogens
Phosphotransferases
Serum Response Element
Phosphorylation
Genetic Suppression
Factor IX
Caspase Inhibitors
Caspase 8
Cell- and Tissue-Based Therapy
Neutralizing Antibodies
Transfection
Neoplasms
Cell Line
Mutation
Therapeutics

Keywords

  • BCCs
  • FAs
  • Hedgehog
  • INFα
  • MEK
  • PDGFRα
  • Smoothened

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. / Li, Chengxin; Chi, Sumin; He, Nonggao; Zhang, Xiaoli; Guicherit, Oivin; Wagner, Richard; Tyring, Stephen; Xie, Jingwu.

In: Oncogene, Vol. 23, No. 8, 26.02.2004, p. 1608-1617.

Research output: Contribution to journalArticle

Li, Chengxin ; Chi, Sumin ; He, Nonggao ; Zhang, Xiaoli ; Guicherit, Oivin ; Wagner, Richard ; Tyring, Stephen ; Xie, Jingwu. / IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. In: Oncogene. 2004 ; Vol. 23, No. 8. pp. 1608-1617.
@article{4679f0a8dd6649c296bdb82a9eaae5cb,
title = "IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling",
abstract = "Basal cell carcinoma (BCC), the most common form of human cancer, is understood to be associated with activation of the sonic hedgehog pathway, through loss-of-function mutations of tumor suppressor PTCH1 or gain-of-function mutations of smoothened. Interferon (IFN)-based therapy is quite effective in BCC treatment, but the molecular basis is not well understood. Here we report a novel mechanism by which IFNα mediates apoptosis in BCCs. In the presence of IFNα, we observed increased apoptosis in a BCC cell line ASZ001, in which PTC is null, and therefore with constitutive activation of the sonic hedgehog pathway. We demonstrate that SMO agonist Ag-1.4 mediates activation of extracellular signal-regulated kinase (Erk) phosphorylation, which is abrogated by IFNα in sonic hedgehog responsive C3H10T1/2 cells. In transient transfection experiments, we demonstrate that IFNα inhibits Erk phosphorylation and serum response element activation induced by expression of SMO, Gli1, PDGFRα and activated Raf, but not activated mitogen-activated Erk-regulating kinase (Mek), suggesting that IFNα targets mainly on Mek function. We further show that IFNa induces expression of Fas in BCC cells through interfering with Mek function. The role of the Fas-L/Fas signaling axis in IFNα-mediated apoptosis is demonstrated by the fact that addition of Fas-L neutralizing antibodies, just as caspase-8 inhibitor Z-IETD-FMK, effectively prevents IFNα-mediated apoptosis. Thus, our data indicate that IFNα-based BCC therapy induces Fas expression and apoptosis through interfering with Mek function.",
keywords = "BCCs, FAs, Hedgehog, INFα, MEK, PDGFRα, Smoothened",
author = "Chengxin Li and Sumin Chi and Nonggao He and Xiaoli Zhang and Oivin Guicherit and Richard Wagner and Stephen Tyring and Jingwu Xie",
year = "2004",
month = "2",
day = "26",
doi = "10.1038/sj.onc.1207273",
language = "English (US)",
volume = "23",
pages = "1608--1617",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling

AU - Li, Chengxin

AU - Chi, Sumin

AU - He, Nonggao

AU - Zhang, Xiaoli

AU - Guicherit, Oivin

AU - Wagner, Richard

AU - Tyring, Stephen

AU - Xie, Jingwu

PY - 2004/2/26

Y1 - 2004/2/26

N2 - Basal cell carcinoma (BCC), the most common form of human cancer, is understood to be associated with activation of the sonic hedgehog pathway, through loss-of-function mutations of tumor suppressor PTCH1 or gain-of-function mutations of smoothened. Interferon (IFN)-based therapy is quite effective in BCC treatment, but the molecular basis is not well understood. Here we report a novel mechanism by which IFNα mediates apoptosis in BCCs. In the presence of IFNα, we observed increased apoptosis in a BCC cell line ASZ001, in which PTC is null, and therefore with constitutive activation of the sonic hedgehog pathway. We demonstrate that SMO agonist Ag-1.4 mediates activation of extracellular signal-regulated kinase (Erk) phosphorylation, which is abrogated by IFNα in sonic hedgehog responsive C3H10T1/2 cells. In transient transfection experiments, we demonstrate that IFNα inhibits Erk phosphorylation and serum response element activation induced by expression of SMO, Gli1, PDGFRα and activated Raf, but not activated mitogen-activated Erk-regulating kinase (Mek), suggesting that IFNα targets mainly on Mek function. We further show that IFNa induces expression of Fas in BCC cells through interfering with Mek function. The role of the Fas-L/Fas signaling axis in IFNα-mediated apoptosis is demonstrated by the fact that addition of Fas-L neutralizing antibodies, just as caspase-8 inhibitor Z-IETD-FMK, effectively prevents IFNα-mediated apoptosis. Thus, our data indicate that IFNα-based BCC therapy induces Fas expression and apoptosis through interfering with Mek function.

AB - Basal cell carcinoma (BCC), the most common form of human cancer, is understood to be associated with activation of the sonic hedgehog pathway, through loss-of-function mutations of tumor suppressor PTCH1 or gain-of-function mutations of smoothened. Interferon (IFN)-based therapy is quite effective in BCC treatment, but the molecular basis is not well understood. Here we report a novel mechanism by which IFNα mediates apoptosis in BCCs. In the presence of IFNα, we observed increased apoptosis in a BCC cell line ASZ001, in which PTC is null, and therefore with constitutive activation of the sonic hedgehog pathway. We demonstrate that SMO agonist Ag-1.4 mediates activation of extracellular signal-regulated kinase (Erk) phosphorylation, which is abrogated by IFNα in sonic hedgehog responsive C3H10T1/2 cells. In transient transfection experiments, we demonstrate that IFNα inhibits Erk phosphorylation and serum response element activation induced by expression of SMO, Gli1, PDGFRα and activated Raf, but not activated mitogen-activated Erk-regulating kinase (Mek), suggesting that IFNα targets mainly on Mek function. We further show that IFNa induces expression of Fas in BCC cells through interfering with Mek function. The role of the Fas-L/Fas signaling axis in IFNα-mediated apoptosis is demonstrated by the fact that addition of Fas-L neutralizing antibodies, just as caspase-8 inhibitor Z-IETD-FMK, effectively prevents IFNα-mediated apoptosis. Thus, our data indicate that IFNα-based BCC therapy induces Fas expression and apoptosis through interfering with Mek function.

KW - BCCs

KW - FAs

KW - Hedgehog

KW - INFα

KW - MEK

KW - PDGFRα

KW - Smoothened

UR - http://www.scopus.com/inward/record.url?scp=1542427154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542427154&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207273

DO - 10.1038/sj.onc.1207273

M3 - Article

C2 - 14647422

AN - SCOPUS:1542427154

VL - 23

SP - 1608

EP - 1617

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 8

ER -